A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation-Reference-Cited by-同舟云学术

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation

Published:2007-02 Issue:2 Volume:45 Page:269-276
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Xu Jing,Shen Zhong-Yang,Chen Xin-Guo,Zhang Qing,Bian Hui-Jie,Zhu Ping,Xu Hui-Yun,Song Fei,Yang Xiang-Min,Mi Li,Zhao Qing-Chuan,Tian Rong,Feng Qiang,Zhang Si-He,Li Yu,Jiang Jian-Li,Li Ling,Yu Xiao-Ling,Zhang Zheng,Chen Zhi-Nan

Publisher

Wiley

Subject

Hepatology

Reference45 articles.

1. A decade's studies on metastasis of hepatocellular carcinoma;Tang;J Cancer Res Clin Oncol,2004

2. Tumor marker for metastasis: searching for an abnormal needle in a haystack;Reid;HEPATOLOGY,1994

3. Expression profiling in hepatocellular carcinoma with intrahepatic metastasis: identification of high-mobility group I(Y) protein as a molecular marker of hepatocellular carcinoma metastasis;Chuma;Keio J Med,2004

4. Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma;Koo;Cancer,1983

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts;Cell Reports Medicine;2024-06

2. Biomarker predictors and LRT strategies for HCC recurrence post-liver transplantation: A comment;Journal of Hepatology;2024-06

3. Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity;MedComm;2024-03

4. Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer;Expert Opinion on Therapeutic Targets;2024-01-23

5. 124I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies;Acta Pharmacologica Sinica;2023-09-25